Home › Astrocytoma › Connecticut › New Haven
Astrocytoma clinical trials in New Haven, CT
3 studies for Astrocytoma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- Yale University, New Haven
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- Yale University, New Haven
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Yale University, New Haven
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- New York City, NY9 studies
- Chicago, IL9 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Seattle, WA7 studies
- Washington, DC6 studies
- Columbus, OH6 studies
- Durham, NC6 studies
- San Francisco, CA5 studies
- Aurora, CO5 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)34 studies
- Metastatic Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Colorectal Cancer21 studies
- Prostate Cancer21 studies
- Ovarian Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.